Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
University of Western Ontario, London, Canada.
B G
BG
Feagan
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D019804:Mesalamine / Q000627:therapeutic use*; D015201:Meta-Analysis as Topic; D011239:Prednisolone / Q000627:therapeutic use; D012460:Sulfasalazine / Q000627:therapeutic use; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D012460:Sulfasalazine; D019804:Mesalamine; D011239:Prednisolone